Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old

NCT02035696 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

671

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Trivalent influenza vaccine (TIVc)
BIOLOGICAL: Trivalent influenza vaccine-licensed

Sponsor

Seqirus

Collaborators

[object Object]